Feinstein Kean Healthcare

Feinstein Kean Healthcare, a wholly owned subsidiary of Ogilvy Public Relations Worldwide, specializes in integrated corporate and product communications for life sciences and healthcare companies and organizations. The firm's Molecular Medicine practice serves the governmental, academic, and private sector organizations that are driving the new generation of technologies and products to transform health care in the 21st century. Feinstein Kean clients include emerging biopharmaceutical companies; four of the world's five largest pharmaceutical companies; government agencies; and policy organizations.